Yezan Munther Haddadin

OTLK

Yezan Munther Haddadin serves as director at Outlook Therapeutics, Inc. (OTLK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$136.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$136.4K

Companies Traded

OTLK

Active Period

Apr 2021 – Jun 2026

6 total trades

Most Recent

Buy OTLK

Jun 3, 2026 · $24.1K

Yezan Munther Haddadin's Insider Trading at Outlook Therapeutics, Inc. (OTLK)

Buys

6 · $136.4K

Sells

0 · $0.00

Total Shares Bought

118,224

Total Shares Sold

OTLK Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2026	Buy	29,000	$0.83	$24.1K	66,167
May 27, 2026	Buy	34,000	$0.44	$15.0K	37,167
Mar 29, 2024	Buy	1,881	$11.82	$22.2K	5,049
Oct 11, 2022	Buy	33,343	$1.29	$42.9K	63,343
Dec 2, 2021	Buy	10,000	$1.39	$13.9K	30,000
Apr 20, 2021	Buy	10,000	$1.82	$18.2K	20,000